Call for Nominations: William B. Abrams Award in Geriatric Clinical Pharmacology
The William B. Abrams Award in Geriatric Clinical Pharmacology was established with support from the Merck Company Foundation in 1996 to honor an investigator in geriatric clinical pharmacology for outstanding contributions to the field.
Dr. Abrams, a Past President of ASCPT, had a long and illustrious career in the pharmaceutical industry, mostly at the Merck Research Laboratories. Among his many accomplishments in geriatric clinical pharmacology, he was the founding Co-Editor of the Merck Manual of Geriatrics, created the Scientific Section on Geriatric Clinical Pharmacology of ASCPT, and developed and funded post-doctoral training programs in geriatric clinical pharmacology.
Dr. Abrams' objective in establishing this award was to encourage more young scientists to enter the field of geriatric clinical pharmacology by recognizing accomplishments in the field at the Society's Annual Meeting.
This award is funded on behalf of Dr. Abrams through the generosity of The Merck Company Foundation.
Eligibility
A nominee must be an investigator in geriatrics who is actively involved in high-quality teaching and research in geriatric clinical pharmacology.
Prize and Presentation
The William B. Abrams Award in Geriatric Clinical Pharmacology is presented at the ASCPT Annual Meeting. The recipient will receive a plaque and a $1,000 honorarium. Travel expenses, hotel expenses and meeting registration will be reimbursed by the Society.
The nomination deadline is Thursday, June 27, 2013.
To submit a nomination, please complete the online nomination form. Please send CVs, letters of support, and other supporting documents to ASCPT at meetings@ascpt.org.
